FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174687002> ?p ?o ?g. }

• W3174687002 abstract "Introduction: The acute physiology, age, chronic Health Evaluation (APACHE) II score has been used to assess risk of mortality in admitted intensive care unit (ICU) patients since 1985. There are few examples of a longitudinal correlation over time. As the scores rises from 0 to 71, risk of mortality increases. For this study, other scores were also considered - SOFA (Sequential Organ Failure Assessment) was excluded due to a lack of variable diversity and small range of values. APACHE III and IV are more complex scores with additional variables, such that calculating daily scores manually was impracticable. APACHE II has consistent calibration compared to III and IV. We assessed whether APACHE III and IV scores had any additional benefit over APACHE II. Methods: APACHE II score was used to determine clinical severity daily of sixteen critically ill COVID-19 patients and compared to daily changes in cytokine levels. If any studies were unavailable for a given day, data was pulled from a maximum of 24 hours before or after the day of interest. Although GCS (Glasgow Coma Scale) is a large part of the score, and difficult to assess in an intubated patient, however it contributed to documenting sedation and intubation state. Results: APACHE II score assessed clinical severity daily in COVID-19 more effectively relative to SOFA. The wide score range allowed comparison of patients without overlap, as compared to SOFA which has a range of 0-24. With a larger range of 0-71, we believe that it increased the sensitivity for detection of small changes in clinical status. We analyzed APACHE II in context of absolute neutrophil count, plasma cytokine levels, as well as neutrophil functional studies. For our study, APACHE II, not SOFA, was helpful in demonstrating changes in severity of illness, which correlated with some of these assessments. For example, APACHE II showed a significant linear correlation with pro-inflammatory cytokine IL-8 in plasma (r2=0.47, p=0.0017;Fig 1). Conclusion: APACHE II was able to define the severity of illness in COVID-19 patients on a daily basis. APACHE II score allowed us to tie immunophenotyping to clinical disease severity over time and was helpful in broadening our approach to data comparison with clinical status. This was a pilot study to assess the ability of APACHE II to track severity of illness, but in the future, we plan to correlate APACHE II in a larger cohort of a variety of ARDS patients." @default.
• W3174687002 created "2021-07-05" @default.
• W3174687002 creator A5058107706 @default.
• W3174687002 creator A5063120434 @default.
• W3174687002 creator A5071781603 @default.
• W3174687002 creator A5091316905 @default.
• W3174687002 date "2021-05-01" @default.
• W3174687002 modified "2023-09-26" @default.
• W3174687002 title "Using APACHE Longitudinally in ARDS to Assess Disease Severity" @default.
• W3174687002 doi "https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2849" @default.
• W3174687002 hasPublicationYear "2021" @default.
• W3174687002 type Work @default.
• W3174687002 sameAs 3174687002 @default.
• W3174687002 citedByCount "0" @default.
• W3174687002 crossrefType "proceedings-article" @default.
• W3174687002 hasAuthorship W3174687002A5058107706 @default.
• W3174687002 hasAuthorship W3174687002A5063120434 @default.
• W3174687002 hasAuthorship W3174687002A5071781603 @default.
• W3174687002 hasAuthorship W3174687002A5091316905 @default.
• W3174687002 hasBestOaLocation W31746870021 @default.
• W3174687002 hasConcept C126322002 @default.
• W3174687002 hasConcept C177713679 @default.
• W3174687002 hasConcept C194828623 @default.
• W3174687002 hasConcept C2776348555 @default.
• W3174687002 hasConcept C2776376669 @default.
• W3174687002 hasConcept C2777714996 @default.
• W3174687002 hasConcept C2780347030 @default.
• W3174687002 hasConcept C30036603 @default.
• W3174687002 hasConcept C71924100 @default.
• W3174687002 hasConceptScore W3174687002C126322002 @default.
• W3174687002 hasConceptScore W3174687002C177713679 @default.
• W3174687002 hasConceptScore W3174687002C194828623 @default.
• W3174687002 hasConceptScore W3174687002C2776348555 @default.
• W3174687002 hasConceptScore W3174687002C2776376669 @default.
• W3174687002 hasConceptScore W3174687002C2777714996 @default.
• W3174687002 hasConceptScore W3174687002C2780347030 @default.
• W3174687002 hasConceptScore W3174687002C30036603 @default.
• W3174687002 hasConceptScore W3174687002C71924100 @default.
• W3174687002 hasLocation W31746870021 @default.
• W3174687002 hasOpenAccess W3174687002 @default.
• W3174687002 hasPrimaryLocation W31746870021 @default.
• W3174687002 hasRelatedWork W2388188491 @default.
• W3174687002 hasRelatedWork W2905955986 @default.
• W3174687002 hasRelatedWork W2921891964 @default.
• W3174687002 hasRelatedWork W2989838482 @default.
• W3174687002 hasRelatedWork W3029405381 @default.
• W3174687002 hasRelatedWork W3115132970 @default.
• W3174687002 hasRelatedWork W3200718815 @default.
• W3174687002 hasRelatedWork W3204266295 @default.
• W3174687002 hasRelatedWork W3215602374 @default.
• W3174687002 hasRelatedWork W4312113552 @default.
• W3174687002 isParatext "false" @default.
• W3174687002 isRetracted "false" @default.
• W3174687002 magId "3174687002" @default.
• W3174687002 workType "article" @default.